title: Preparation and physicochemical evaluation of a new tacrolimus tablet formulation for sublingual administration.
abstract: The aim of this study was to develop a new fast-disintegrating tablet formulation containing 1 mg tacrolimus for sublingual application. First, solid dispersions containing tacrolimus (2.5%, 5% and 10% w/w) incorporated in Ac-Di-Sol(®) and carriers (inulin 1.8 kDa and 4 kDa, and polyvinylpyrrolidone (PVP) K30) were prepared by freeze drying. Subsequently, a tablet formulation composed of a mixture of the solid dispersions, Ac-Di-Sol(®), mannitol, Avicel(®) PH-101 and sodium stearyl fumarate was optimized concerning drug load in the solid dispersions and the type of carrier. Tablet weight was kept constant at 75 mg by adjusting the amount of Avicel(®) PH-101. Differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) results indicated the absence of the drug in the crystalline state, which was confirmed by the scanning electron microscopy (SEM). These results suggest that tacrolimus incorporated in all of the solid dispersions was fully amorphous. Dissolution of the tablets containing solid dispersions with a low drug load highly depends on the type of carrier and increased in the order: PVP K30 < inulin 4 kDa < inulin 1.8 kDa. Solid dispersions with a drug load of 10% w/w incorporated in the carriers yielded optimal formulations. In addition, the physicochemical characteristics and the dissolution behavior of the tablet formulation containing inulin 1.8 kDa-based solid dispersions with a drug load of 10% w/w did not change after storage at 20°C/45%RH for 6 months indicating excellent storage stability.
authors.affiliation: Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands. P.srinarong@rug.nl
authors.forename: Parinda
authors.initials: P
authors.lastname: Srinarong
authors.forename: Bao T
authors.initials: BT
authors.lastname: Pham
authors.forename: Maru
authors.initials: M
authors.lastname: Holen
authors.forename: Afke
authors.initials: A
authors.lastname: van der Plas
authors.forename: Reinout C A
authors.initials: RC
authors.lastname: Schellekens
authors.forename: Wouter L J
authors.initials: WL
authors.lastname: Hinrichs
authors.forename: Henderik W
authors.initials: HW
authors.lastname: Frijlink
mesh_terms: D000286:Administration, Sublingual; D001682:Biological Availability; D004337:Drug Carriers; D004339:Drug Compounding / Q000379:methods*; D004355:Drug Stability; D005612:Freeze Drying; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000737:chemistry*; D007444:Inulin / Q000008:administration & dosage; D008855:Microscopy, Electron, Scanning; D011205:Povidone / Q000008:administration & dosage; D013607:Tablets / Q000008:administration & dosage / Q000737:chemistry*; D016559:Tacrolimus / Q000008:administration & dosage / Q000737:chemistry*
chemical_list: D004337:Drug Carriers; D007166:Immunosuppressive Agents; D013607:Tablets; D007444:Inulin; D011205:Povidone; D016559:Tacrolimus